Your browser doesn't support javascript.
loading
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study.
Palmeri, Serena; Ponzano, Marta; Ivaldi, Federico; Signori, Alessio; Lapucci, Caterina; Casella, Valentina; Ferrò, Maria Teresa; Vigo, Tiziana; Inglese, Matilde; Mancardi, Giovanni Luigi; Uccelli, Antonio; Laroni, Alice.
Affiliation
  • Palmeri S; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132, Genoa, Italy.
  • Ponzano M; University of Genova and IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Ivaldi F; Department of Health Sciences, Section of Biostatistics, University of Genova, Genoa, Italy.
  • Signori A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132, Genoa, Italy.
  • Lapucci C; Department of Health Sciences, Section of Biostatistics, University of Genova, Genoa, Italy.
  • Casella V; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132, Genoa, Italy.
  • Ferrò MT; IRRCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.
  • Vigo T; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132, Genoa, Italy.
  • Inglese M; Neuroimmunology, Center for Multiple Sclerosis, Cerebrovascular Department, ASST Crema, Crema, Italy.
  • Mancardi GL; IRRCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.
  • Uccelli A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132, Genoa, Italy.
  • Laroni A; IRRCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.
CNS Drugs ; 36(1): 83-96, 2022 01.
Article in En | MEDLINE | ID: mdl-34894339

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Multiple Sclerosis, Relapsing-Remitting / Alemtuzumab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Observational_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Italy Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Multiple Sclerosis, Relapsing-Remitting / Alemtuzumab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Observational_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Document type: Article Affiliation country: Italy Country of publication: New Zealand